| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:VU0090157
CAS:312622-77-8
Package:25mg/RMB 10600;100mg/RMB 17500;50mg/RMB 13800
|
| Company Name: |
VITAS-M LABORATORY, LTD.
|
| Tel: |
+7 495 939 48 31 |
| Email: |
|
| Products Intro: |
Product Name:cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
CAS:312622-77-8
Purity:90%+ Package:1mg
|
cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate manufacturers
- VU0090157
-
- $1520.00 / 25mg
-
2026-01-05
- CAS:312622-77-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate Basic information |
| Product Name: | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | | Synonyms: | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate;5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-, cyclopentyl ester;VU 0090157;VU0090157;VU-0090157 | | CAS: | 312622-77-8 | | MF: | C19H21N3O7 | | MW: | 403.39 | | EINECS: | | | Product Categories: | | | Mol File: | 312622-77-8.mol |  |
| | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate Chemical Properties |
| | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate Usage And Synthesis |
| Description | VU0090157 is a novel allosteric potentiators of M1 muscarinic receptor which may provide novel treatments for schizophrenia and Alzheimer's disease. | | Uses | VU0090157 is a positive allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (mAChR). VU0090157 increases the affinity of ACh by binding to the allosteric site. VU0090157 can be used in the study of schizophrenia and Alzheimer's disease[1]. | | References | [1] Marlo J E, et al. Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity[J]. Molecular pharmacology, 2009, 75(3): 577-588. DOI:10.1124/mol.108.052886 |
| | cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate Preparation Products And Raw materials |
|